Effect of Echinacea Purpurea Extract on Anxiety-Like Behaviors in Neonatal Rats

Authors

  • Batool Ghorbani Yekta Islamic Azad University, Tehran Medical Sciences Branch, Tehran, Iran.
  • Noushin Zahra Ahmadzadehfar Herbal Pharmacology Research Center, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
  • Sepideh Yazdanjo Herbal Pharmacology Research Center, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran

DOI:

https://doi.org/10.31661/gmj.v6i1.840

Keywords:

Echinacea Purpurea, Anxiety, Elevated Plus-Maze

Abstract

Background: The use of herbal products is increased among people wordwide. Regarding lacking evidence on the use of herbal medication in children, this study was aimed to determine the effects of Echinacea Purpurea extract on anxiety-like behavior in neonatal rats. Materials and Methods: Forty male Wister strain pups in four groups received i.p injections of E. Purpurea extract (40, 80, and 250 mg/kg) or saline on 5th to 9th postnatal days. All pups were examined for anxiety test on the 22nd postnatal day in the elevated plus-maze test. During the test, parameters include percentage of open arm time (%OAT), percentage of open arm entry (%OAE), head dipping, rearing and locomotor activity have been measured. Results: In the present study, administration of 40, 80 and 250mg/kg doses of the E. Purpurea extract revealed a significant decrease in the %OAT compared to saline group (P<0.01). The E. Purpurea extract decreased head dipping parameters (P<0.01) and increased rearing parameters (P<0.01). E. Purpurea did not significantly change the locomotor activity. Conclusions: The results of present study showed that postnatal administration of E. Purpurea extract increases anxiety in neonatal rats comparing to control group. [GMJ.2017;6(1):52-60]

References

Haller J, Hohmann J, Freund TF. The effect of Echinacea preparations in three laboratory tests of anxiety: comparison with chlordiazepoxide. Phytother Res: PTR. 2010;24(11):1605-13.

Yadollah-Damavandi S, Chavoshi-Nejad M, Jangholi E, Nekouyian N, Hosseini S, Seifaee A, et al. Topical Hypericum perforatum Improves Tissue Regeneration in Full-Thickness Excisional Wounds in Diabetic Rat Model. Evid Based Complement Alternat Med. 2015; 2015:245328.

Mark JD, Grant KL, Barton LL. The Use of Dietary Supplements in Pediatrics: A Study of Echinacea. Clin Pediatr (Phila). 2001;40(5):265-9.

Spigelblatt L, Laine-Ammara G, Pless IB, Guyver A. The use of alternative medicine by children. Pediatrics. 1994;94(6 Pt 1):811-4.

Soo I, Mah JK, Barlow K, Hamiwka L, Wirrell E. Use of complementary and alternative medical therapies in a pediatric neurology clinic. Can J Neurol Sci. 2005;32(4):524-8.

Hobbs C. Echinacea: The Immune Herb! Santa Cruz, Ca: Botanica Press; 1990.

Foster S, Tyler V. The honest herbal. Binghampton, NY; Haworth press, 4th ed., 1999.

Barnes J, Anderson LA, Gibbons S, Phillipson JD. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties .J Pharm Pharmacol. 2005;57(8):929-54.

Borchers AT, Keen CL, Stern JS, Gershwin ME. Inflammation and Native American medicine: the role of botanicals. Am J Clin Nutr. 2000;72(2):339-47.

Fardet L, Kassar A, Cabane J, Flahault A. Corticosteroid-induced adverse events in adults: frequency, screening and prevention. Drug Saf. 2007;30(10):861-81.

Cohen HA, Varsano I, Kahan E, Sarrell EM, Uziel Y. Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study. Arch Pediatr Adolesc Med. 2004;158(3):217-21.

Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8-19.

Kessler RC, Avenevoli S, Costello EJ, Georgiades K, Green JG, Gruber MJ, et al. Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. Arch Gen Psychiatry. 2012;69(4):372-80.

Flagel SB, Vazquez DM, Watson SJ, Jr., Neal CR, Jr. Effects of tapering neonatal dexamethasone on rat growth, neurodevelopment, and stress response. Am J Physiol Regul Integr Comp Physiol. 2002;282(1):R55-63.

Neal CR, Jr., Weidemann G, Kabbaj M, Vazquez DM. Effect of neonatal dexamethasone exposure on growth and neurological development in the adult rat. Am J Physiol Regul Integr Comp Physiol. 2004;287(2):R375-85.

Onaolapo OJ, Onaolapo AY, Awe EO, Jibunor N, Oyeleke B, Ogedengbe AJ. Oral artesunate-amodiaquine combination causes anxiolysis and impaired cognition in healthy Swiss mice. IOSR: JPBS. 2013;7(2):97-102.

Kamphuis PJ, Croiset G, Bakker JM, Van Bel F, Van Ree JM, Wiegant VM. Neonatal dexamethasone treatment affects social behaviour of rats in later life. Neuropharmacology. 2004;47(3):461-74.

Velíšek L. Prenatal exposure to betamethasone decreases anxiety in developing rats: hippocampal neuropeptide y as a target molecule. Neuropsychopharmacology. 2006 Oct 1;31(10):2140-9.

Takeda H, Tsuji M, Matsumiya T. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur J Pharmacol. 1998;350(1):21-9.

Broderick PA, Hope O, Jeannot P. Mechanism of triazolo-benzodiazepine and benzodiazepine action in anxiety and depression: behavioral studies with concomitant in vivo CA1 hippocampal norepinephrine and serotonin release detection in the behaving animal. Prog Neuropsychopharmacol Biol Psychiatry. 1998;22(2):353-86.

Welberg LA, Seckl JR, Holmes MC. Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behaviour. Neuroscience. 2001;104(1):71-9.

Dielenberg RA, McGregor IS. Defensive behavior in rats towards predatory odors: a review. Neuroscience. 2001; 25:597–609.

McGregor IS, Hargreaves GA, Apfelbach R, Hunt GE. Neural correlates of cat odor-induced anxiety in rats: region-specific effects of the benzodiazepine midazolam. J Neurosci. 2004;24(17):4134-44.

Haller J, Freund TF, Pelczer KG, Furedi J, Krecsak L, Zambori J. The anxiolytic potential and psychotropic side effects of an echinacea preparation in laboratory animals and healthy volunteers. Phytotherapy research: Phytother Res. 2013;27(1):54-61.

Cuzzolin L, Francini-Pesenti F, Verlato G, Joppi M, Baldelli P, Benoni G. Use of herbal products among 392 Italian pregnant women: focus on pregnancy outcome. Pharmacoepidemiol Drug Saf. 2010;19(11):1151-8.

Birt DF, Widrlechner MP, Lalone CA, Wu L, Bae J, Solco AK, et al. Echinacea in infection. Am J Clin Nutr. 2008;87(2):488s-92s.

Woelkart K, Xu W, Pei Y, Makriyannis A, Picone RP, Bauer R. The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots. Planta Med. 2005;71(8):701-5.

Pertwee RG. The pharmacology of cannabinoid receptors and their ligands: an overview. Int J Obes (Lond) (2005). 2006;30 Suppl 1: S13-8.

Chaperon F, Thiebot MH. Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol. 1999;13(3):243-81.

Woelkart K, Frye RF, Derendorf H, Bauer R, Butterweck V. Pharmacokinetics and tissue distribution of dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides after oral administration in rats. Planta Med. 2009;75(12):1306-13.

Konishi Y, Hitomi Y, Yoshida M, Yoshioka E. Pharmacokinetic study of caffeic and rosmarinic acids in rats after oral administration. J Agric Food Chem. 2005;53(12):4740-6.

Viveros MP, Llorente R, Moreno E, Marco EM. Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods. Behav Pharmacol. 2005;16(5-6):353-62.

Moreira FA, Wotjak CT. Cannabinoids and anxiety. Curr Top Behav Neurosci.2010;2:429-50.

Haller J, Bakos N. Stress-induced social avoidance: a new model of stress-induced anxiety? Physiol Behav. 2002;77(2-3):327-32.

Navarro M, Hernandez E, Munoz RM, del Arco I, Villanua MA, Carrera MR, et al. Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. Neuroreport. 1997;8(2):491-6.

Kennedy DO, Little W, Haskell CF, Scholey AB. Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress. Phytother Res: 2006;20(2):96-102.

Viveros MP, Marco EM, File SE. Endocannabinoid system and stress and anxiety responses. Pharmacol Biochem Behav. 2005;81(2):331-42.

Nordeng H, Havnen GC. Impact of socio-demographic factors, knowledge and attitude on the use of herbal drugs in pregnancy. Acta Obstet Gynecol Scand. 2005;84(1):26-33.

Holst L, Wright D, Haavik S, Nordeng H. The use and the user of herbal remedies during pregnancy. J Altern Complement Med. 2009;15(7):787-92.

Tehrani S, Lotfi P, Tehrani S, Jangholi E, Aryan H, Aidun A. Healing Effect of Sesame Ointment on Second-degree Burn Wound in Rats. Galen Medical Journal. 2016;5(2):56-62.

Bafrani HH, Parsa Y, Yadollah-Damavandi S, Jangholi E, Ashkani-Esfahani S, Gharehbeglou M. Biochemical and Pathological Study of Hydroalcoholic Extract of Achillea millefolium L. on Ethylene Glycol-Induced Nephrolithiasis in Laboratory Rats. N Am J Med Sci.. 2014;6(12):638-42.

Downloads

Additional Files

Published

2017-04-01

Issue

Vol. 6 No. 1 (2017): March 2017

Section

Original Article

License

Copyright (c) 2017 Galen Medical Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

https://creativecommons.org/licenses/by/4.0/